13F Filings History of Context Capital Management, LLC

Latest 13F report
Q4 2025 - 13 Feb 2026
Value $
$3,880,974,285
Signature - Title
Grace Brescia - Director of Compliance
Location
Lajolla, CA
Summary
This page shows a list of all the recent 13F filings made by Context Capital Management, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Context Capital Management, LLC reported 327 stock holdings with total value $3,880,974,285 as of Q4 2025. Top holdings included STRATEGY INC, ECHOSTAR CORP, PELOTON INTERACTIVE INC, MARA HOLDINGS INC, and CONMED CORP.

Notify me when Context Capital Management, LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 327 $3,880,974,285 +$3,651,519,532 -$504,727,292 +$3,146,792,240 STRATEGY INC, ECHOSTAR CORP, PELOTON INTERACTIVE INC, MARA HOLDINGS INC, CONMED CORP 13F-HR 13 Feb 2026, 15:33
Q3 2025 267 $1,474,664,860 +$579,522,424 -$571,103,236 +$8,419,188 ECHOSTAR CORP, EQUINOX GOLD CORP, GROUPON INC, IMMUNOCORE HLDGS PLC, CENTURY ALUM CO 13F-HR 12 Nov 2025, 14:53
Q2 2025 251 $1,958,086,820 +$691,521,140 -$415,543,932 +$275,977,208 PELOTON INTERACTIVE INC, PACIRA BIOSCIENCES INC, IMMUNOCORE HLDGS PLC, BRIDGEBIO PHARMA INC, SOLAREDGE TECHNOLOGIES INC 13F-HR 06 Aug 2025, 10:02
Q1 2025 208 $1,507,524,418 +$421,688,957 -$319,920,154 +$101,768,803 3D SYS CORP DEL, GROUPON INC, EQUINOX GOLD CORP, SOLAREDGE TECHNOLOGIES INC, COHERUS BIOSCIENCES INC 13F-HR 05 May 2025, 11:37
Q4 2024 238 $1,250,669,439 +$391,745,681 -$1,398,542,768 -$1,006,797,087 3D SYS CORP DEL, REVANCE THERAPEUTICS INC, COHERUS BIOSCIENCES INC, ALPHATEC HLDGS INC, GROUPON INC 13F-HR 11 Feb 2025, 10:47
Q3 2024 284 $1,779,522,739 +$774,694,345 -$183,564,044 +$591,130,301 ROCKETLAB USA INC, PELOTON INTERACTIVE INC, NEXTERA ENERGY PARTNERS LP, BEAUTY HEALTH CO, ALPHATEC HLDGS INC 13F-HR 14 Nov 2024, 14:47
Q2 2024 222 $1,503,792,085 +$650,098,079 -$292,100,763 +$357,997,316 THE BEAUTY HEALTH COMPANY, 3D SYS CORP DEL, NEXTERA ENERGY PARTNERS LP, ESPERION THERAPEUTICS INC NE, ALPHATEC HLDGS INC 13F-HR 09 Aug 2024, 15:21
Q1 2024 277 $1,594,261,483 +$408,396,283 -$1,070,885,961,578 -$1,070,477,565,295 BEAUTY HEALTH CO, PELOTON INTERACTIVE INC, MICROSTRATEGY INC, 3D SYS CORP DEL, ALPHATEC HLDGS INC 13F-HR 02 May 2024, 15:51
Q4 2023 281 $1,488,903,696 +$1,462,894,382 -$113,967,336 +$1,348,927,046 PELOTON INTERACTIVE INC, WAYFAIR INC, WAYFAIR INC, COINBASE GLOBAL INC, MICROSTRATEGY INC Restatement 16 Feb 2024, 17:02
Q3 2023 301 $457,434,743 +$86,492,013 -$52,135,136 +$34,356,877 OMEROS CORP, TRAVERE THERAPEUTICS INC, MANNKIND CORP, INTERCEPT PHARMACEUTICALS IN, ACCOLADE INC 13F-HR 13 Nov 2023, 09:40
Q2 2023 311 $400,265,887 +$46,611,669 -$185,386,005 -$138,774,336 MICROSTRATEGY INC, OMEROS CORP, ACCOLADE INC, MANNKIND CORP, ARTIVION INC 13F-HR 10 Aug 2023, 16:51
Q1 2023 340 $717,232,280 +$207,187,415 -$371,188,041 -$164,000,626 OMEROS CORP, NIO INC, MICROSTRATEGY INC, ACCOLADE INC, BLOCK INC 13F-HR 08 May 2023, 14:38
Q4 2022 440 $438,598,359 +$73,014,354 -$371,772,621 -$298,758,267 INTERCEPT PHARMACEUTICALS IN, ARTIVION INC, GSRM, CVII, KARYOPHARM THERAPEUTICS INC 13F-HR 14 Feb 2023, 09:31
Q3 2022 587 $1,126,636,705 +$223,663,902 -$206,001,551 +$17,662,351 PELOTON INTERACTIVE INC, LIVEPERSON INC, PEGASYSTEMS INC, INFINERA CORP, VAREX IMAGING CORP 13F-HR 07 Nov 2022, 13:34
Q2 2022 619 $1,212,866,240 +$249,419,784 -$321,819,235 -$72,399,451 THERAVANCE BIOPHARMA INC, INFINERA CORP, VAREX IMAGING CORP, MANNKIND CORP, LIVEPERSON INC 13F-HR 03 Aug 2022, 13:22
Q1 2022 687 $1,292,421,581 +$849,488,638 -$657,098,635 +$192,390,003 THERAVANCE BIOPHARMA INC, VAREX IMAGING CORP, INFINERA CORP, BLOOM ENERGY CORP, OMEROS CORP 13F-HR 09 May 2022, 16:12
Q4 2021 554 $979,600,976 +$537,447,094 -$293,863,283 +$243,583,811 VAREX IMAGING CORP, THERAVANCE BIOPHARMA INC, BLOOM ENERGY CORP, OMEROS CORP, TWO HARBORS INVENTMENT CORPO 13F-HR 09 Feb 2022, 14:26
Q3 2021 472 $705,646,078 +$233,036,902 -$197,031,898 +$36,005,004 VAREX IMAGING CORP, DWACU, VEONEER INC, TWO HBRS INVT CORP, EVENTBRITE INC 13F-HR 12 Nov 2021, 10:32
Q2 2021 520 $520,319,630 +$110,990,584 -$114,717,675 -$3,727,091 NIO INC, CFIVU, AQNU, CVIIU, GIG 13F-HR 16 Aug 2021, 18:54
Q1 2021 462 $530,785,019 +$381,658,321 -$35,547,876,184 -$35,166,217,863 SEA LTD, SEACOR HOLDINGS INC, NANTHEALTH INC, NIO INC, CFIVU 13F-HR 17 May 2021, 11:07
Q4 2020 260 $727,653,550 +$455,450,415 -$215,994,299 +$239,456,116 8X8 INC NEW, INFINERA CORPORATION, GRANITE CONSTR INC, FLEXION THERAPEUTICS INC, PRA GROUP INC 13F-HR 12 Feb 2021, 14:40
Q3 2020 164 $448,322,000 +$304,826,840 -$123,426,883 +$181,399,957 8X8 INC NEW, SEA LTD, VEONEER INCORPORATED, INTERCEPT PHARMACEUTICALS IN, AMAG PHARMACEUTICALS INC 13F-HR 16 Nov 2020, 16:47
Q2 2020 103 $254,940,000 +$96,009,901 -$61,608,717 +$34,401,184 INOVIO PHARMACEUTICALS INC, OPKO HEALTH INC, INTERCEPT PHARMACEUTICALS IN, CYTOKINETICS INC, SEA LTD 13F-HR 11 Aug 2020, 15:53
Q1 2020 101 $176,106,000 +$74,137,621 -$2,566,806,397 -$2,492,668,776 INOVIO PHARMACEUTICALS INC, HYG, NANTHEALTH INC, IQIYI INC, OPKO HEALTH INC 13F-HR 11 May 2020, 17:43
Q4 2019 100 $199,554,000 +$53,534,672 -$38,790,275 +$14,744,397 AMAG PHARMACEUTICALS INC, IQIYI INC, THERAVANCE BIOPHARMA INC, OPKO HEALTH INC, ASSERTIO THERAPEUTICS INC 13F-HR 07 Feb 2020, 13:58
Q3 2019 90 $176,444,000 +$53,045,944 -$48,975,917 +$4,070,027 PDL BIOPHARMA INC, TEAM INC, AMAG PHARMACEUTICALS INC, IQIYI INC, OPKO HEALTH INC 13F-HR 01 Nov 2019, 09:47
Q2 2019 89 $172,413,000 +$63,407,029 -$44,006,768 +$19,400,261 AMAG PHARMACEUTICALS INC, PDL BIOPHARMA INC, OPKO HEALTH INC, TEAM INC, IQIYI INC 13F-HR 14 Aug 2019, 16:11
Q1 2019 84 $163,741,000 +$36,688,891 -$71,250,740 -$34,561,849 TIBRU, PDL BIOPHARMA INC, AMAG PHARMACEUTICALS INC, IQIYI INC, THERAVANCE BIOPHARMA INC 13F-HR 10 May 2019, 17:44
Q4 2018 80 $177,043,000 +$58,893,981 -$45,608,796 +$13,285,185 PDL BIOPHARMA INC, AMAG PHARMACEUTICALS INC, RESTORATION HARDWARE HLDGS I, TWO HBRS INVT CORP, THERAVANCE BIOPHARMA INC 13F-HR 13 Feb 2019, 12:13
Q3 2018 69 $171,620,000 +$75,542,850 -$27,232,890 +$48,309,960 AMAG PHARMACEUTICALS INC, RESTORATION HARDWARE HLDGS I, TWO HBRS INVT CORP, THERAVANCE BIOPHARMA INC, PDL BIOPHARMA INC 13F-HR 04 Mar 2019, 15:32
Q2 2018 44 $115,818,000 +$28,656,158 -$51,727,968 -$23,071,810 AMAG PHARMACEUTICALS INC, RENEWABLE ENERGY GROUP INC, PDL BIOPHARMA INC, THERAVANCE BIOPHARMA INC, VECTOR GROUP LTD 13F-HR 13 Aug 2018, 14:24
Q1 2018 51 $137,790,000 +$42,783,509 -$74,128,073 -$31,344,564 PDL BIOPHARMA INC, AMAG PHARMACEUTICALS INC, CARRIAGE SVCS INC, SPY, TWO HBRS INVT CORP 13F-HR 14 May 2018, 16:35
Q4 2017 45 $168,305,000 +$43,055,072 -$30,280,029 +$12,775,043 LGI HOMES INC, PDL BIOPHARMA INC, TWO HBRS INVT CORP, CARRIAGE SVCS INC, CAESARS ENTMT CORP 13F-HR 13 Feb 2018, 14:51
Q3 2017 41 $149,449,000 +$36,808,732 -$30,778,471 +$6,030,261 LGI HOMES INC, TTM TECHNOLOGIES INC, PDL BIOPHARMA INC, TWO HBRS INVT CORP, CARRIAGE SVCS INC 13F-HR 17 Nov 2017, 13:35
Q2 2017 40 $140,616,000 +$34,718,778 -$23,822,224 +$10,896,554 TTM TECHNOLOGIES INC, LGI HOMES INC, PDL BIOPHARMA INC, TESLA INC, SOLARCITY CORP 13F-HR 14 Aug 2017, 16:20
Q1 2017 38 $125,084,000 +$54,019,260 -$26,143,746 +$27,875,514 TTM TECHNOLOGIES INC, LGI HOMES INC, PDL BIOPHARMA INC, CARRIAGE SVCS INC, SOLARCITY CORP 13F-HR 12 May 2017, 15:00
Q4 2016 31 $91,266,000 +$39,693,762 -$46,926,101 -$7,232,339 ENDOLOGIX INC, LGI HOMES INC, PDL BIOPHARMA INC, ALBANY MOLECULAR RESH INC, SPECTRUM PHARMACEUTICALS INC 13F-HR 14 Feb 2017, 12:27
Q3 2016 33 $102,234,000 +$41,242,735 -$28,879,288 +$12,363,447 ENDOLOGIX INC, MENTOR GRAPHICS CORP, VERISIGN INC, ALBANY MOLECULAR RESH INC, LGI HOMES INC 13F-HR 14 Nov 2016, 12:29
Q2 2016 37 $84,512,000 +$34,063,524 -$32,236,799 +$1,826,725 MENTOR GRAPHICS CORP, WEATHERFORD INTERNATIONAL, ENDOLOGIX INC, PDL BIOPHARMA INC, ALBANY MOLECULAR RESEARCH Restatement 18 Aug 2016, 14:33
Q1 2016 47 $80,444,000 +$21,421,686 -$2,821,904 +$18,599,782 ALBANY MOLECULAR RESEARCH INC, AFFYMETRIX INC., SEACOR HOLDINGS INC, PDL BIOPHARMA INC, VECTOR GROUP LTD 13F-HR 26 Apr 2016, 14:33
Q4 2015 41 $64,044,000 +$19,637,158 -$10,001,696 +$9,635,462 SEACOR HOLDINGS INC, VECTOR GROUP LTD, AFFYMETRIX INC, ENDOLOGIX INC, SEQUENOM INC 13F-HR 04 Feb 2016, 14:55
Q3 2015 37 $54,896,000 +$13,324,550 -$10,903,343 +$2,421,207 AFFYMETRIX INC, VECTOR GROUP LTD, SEACOR HOLDINGS INC, SEQUENOM INC, PDL BIOPHARMA INC 13F-HR 17 Nov 2015, 16:29
Q2 2015 35 $57,767,000 +$22,655,907 -$19,508,844 +$3,147,063 AFFYMETRIX INC, SEQUENOM INC, VECTOR GROUP LTD, PDL BIOPHARMA INC, ENCORE CAPITAL GROUP INC 13F-HR 15 Jul 2015, 12:40
Q1 2015 35 $55,174,000 +$20,403,964 -$17,635,291 +$2,768,673 AFFYMETRIX INC, SEQUENOM INC, VECTOR GROUP LTD, BLUCORA INC, QUIDEL CORP 13F-HR 28 Apr 2015, 14:06
Q4 2014 37 $75,481,000 $0 $0 $0 GGACW, AFFYMETRIX INC, AK STEEL HOLDING CORP, BLUCORA INC, ANI PHARMACEUTICALS INC Restatement 17 Feb 2015, 16:39